Evidence map›Paper›PMID 32304142›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model.

Aline de Conti, Volodymyr Tryndyak, Rose A Willett, Barbara Borowa-Mazgaj, Anna Watson, Ralph Patton, Sangeeta Khare, Levan Muskhelishvili, Greg R Olson, Mark I Avigan and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Mediation analysis of the molecular phenotypes in a severe MASH-like liver injury mouse model.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Aline de ContiDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Volodymyr TryndyakDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Rose A WillettDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Barbara Borowa-MazgajDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Anna WatsonDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Ralph PattonToxicologic Pathology Associates, Jefferson, AR, USA.
Sangeeta KhareDivision of Microbiology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Levan MuskhelishviliToxicologic Pathology Associates, Jefferson, AR, USA.
Greg R OlsonToxicologic Pathology Associates, Jefferson, AR, USA.
Mark I AviganOffice of Pharmacovigilance and Epidemiology, FDA-Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Carl E CernigliaDivision of Microbiology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Sharon A RossDivision of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Arun J SanyalDepartment of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Frederick A BelandDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
Ivan RusynDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.
Igor P PogribnyDivision of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, AR, USA.
National Center for Toxicological Research · USCenter for Drug Evaluation and Research · USNational Cancer Institute · USTexas A&M University · USVirginia Commonwealth University · US

Funding

Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu · 2017 to 2026
$21.2M
Texas A&M Center for Environmental Health Research (TiCER)P30ES029067 · NIEHS · TEXAS A&M UNIVERSITY · PI Galen Newman · 2019 to 2026
$13.0M
HHS | U.S. Food and Drug Administration (FDA) E7635.01NIEHS NIH HHS P30 ES029067NIEHS NIH HHS P42 ES027704
6 · The paper itself

Abstract

Interindividual variability and sexual dimorphisms in the development of nonalcoholic fatty liver disease (NAFLD) are still poorly understood. In the present study, male and female strains of Collaborative Cross (CC) mice were fed a high-fat and high-sucrose (HF/HS) diet or a control diet for 12 weeks to investigate interindividual- and sex-specific variations in the development of NAFLD. The severity of liver steatosis varied between sexes and individual strains and was accompanied by an elevation of serum markers of insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-density lipoproteins, phospholipids, and glucose. The development of NAFLD was associated with overexpression of the critical fatty acid uptake and de novo lipogenesis genes Pparg, Mogat1, Cd36, Acaab1, Fabp2, and Gdf15 in male and female mice. The expression of Pparg, Mogat1, and Cd36 was positively correlated with liver triglycerides in male mice, and Mogat1 and Cd36 expression were positively correlated with liver triglycerides in female mice. Our results indicate the value of CC mice in combination with HF/HS diet-induced alterations as an approach to study the susceptibility and interindividual variabilities in the pathogenesis of nonalcoholic fatty liver and early nonalcoholic steatohepatitis at the population level, uncovering of susceptible and resistant cohorts, and identifying sex-specific molecular determinants of disease susceptibility.

Indexed as

AnimalsCollaborative Cross MiceDiet, High-FatDisease Models, AnimalDisease SusceptibilityFatty AcidsFemaleInsulin ResistanceLipogenesisLiverMaleMiceNon-alcoholic Fatty Liver DiseaseObesitySex FactorsTriglyceridesFatty AcidsTriglyceridesCd36collaborative cross micegene expressionnonalcoholic fatty liver disease

Identifiers

PMID32304142
PMCPMC7552439
OpenAlexW3016656470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.